Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 25

Results For "company"

4248 News Found

Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations
People | August 01, 2025

Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations

Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics


Jubilant Ingrevia Q1 FY26 YoY net profit jumps 54% to Rs. 75 Cr
News | August 01, 2025

Jubilant Ingrevia Q1 FY26 YoY net profit jumps 54% to Rs. 75 Cr

Our specialty chemical businesses have continued to perform strongly, growing double digit YoY


Asahi Kasei Life Science to construct new plant for Planova virus removal filters
News | July 31, 2025

Asahi Kasei Life Science to construct new plant for Planova virus removal filters

The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters


Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, and Head of Development
People | July 31, 2025

Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, and Head of Development

He most recently served as Chief Medical Officer of AstraZeneca and Alexion


Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine with near-zero GWP
Sustainability | July 31, 2025

Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine with near-zero GWP

Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant


Maziar Mike Doustdar appointed President and CEO of Novo Nordisk
People | July 31, 2025

Maziar Mike Doustdar appointed President and CEO of Novo Nordisk

Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit


Vijaya Diagnostic reports Q1 FY26 consolidated PAT at Rs. 38.33 Cr
News | July 30, 2025

Vijaya Diagnostic reports Q1 FY26 consolidated PAT at Rs. 38.33 Cr

The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal


Ajanta Pharma reports Q1 FY26 consolidated PAT at Rs. 255.34 Cr
News | July 30, 2025

Ajanta Pharma reports Q1 FY26 consolidated PAT at Rs. 255.34 Cr

Ajanta Pharma has reported total income of Rs. 1,328.98 crores during the period ended June 30, 2025


Novartis India posts Q1 FY26 net profit at Rs. 27.62 Cr
News | July 30, 2025

Novartis India posts Q1 FY26 net profit at Rs. 27.62 Cr

Novartis India has reported total income of Rs. 98.16 crores during the period ended June 30, 2025


Torrent Pharmaceuticals posts Q1 FY26 consolidated PAT higher at Rs. 548 Cr
News | July 30, 2025

Torrent Pharmaceuticals posts Q1 FY26 consolidated PAT higher at Rs. 548 Cr

Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025